Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Origin Therapeutics Holdings, Inc. ( (TSE:SPLY) ) has shared an announcement.
Safe Supply Streaming Co Ltd. has positioned itself as a major player in the fight against the fentanyl crisis by acquiring Drug Lab 118 Ltd. and securing distribution rights to its proprietary test kits. These kits are intended to aid law enforcement, border security, retailers, and consumers in detecting and preventing fentanyl-related harm. Amid rising trade tensions and U.S. policy measures aimed at controlling illicit fentanyl flows, Safe Supply aims to support domestic enforcement initiatives, emphasizing its strategic alignment with government efforts to combat the epidemic.
More about Origin Therapeutics Holdings, Inc.
Safe Supply Streaming Co Ltd. is a company dedicated to combating the fentanyl crisis through the distribution of proprietary fentanyl test kits. The company focuses on national security, consumer safety, and retail distribution by providing tools for early detection and testing of fentanyl at borders and other points of entry. Safe Supply is positioned as a leader in the fight against fentanyl trafficking and overdose prevention, primarily in North America.
YTD Price Performance: 33.33%
Average Trading Volume: 124,259
Technical Sentiment Consensus Rating: Sell
For detailed information about SPLY stock, go to TipRanks’ Stock Analysis page.